RxDoctor Payments DataLook up a doctor →

Mayur Ramesh, MD

Infectious Disease · Detroit, MINPI 1043275167

Payments from drug & device makers

$1,660,053in general payments, 2019–2025

Across 248 payments — averaging $6693.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Research & Development, LLC$634K
  • Eli Lilly$252K
  • Pfizer$173K
  • Merck$125K
  • Bavarian Nordic A/s$97K
  • Modernatx, Inc.$66K
  • plus $314K from 11 others

General payments by program year

20
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,660,053 in reported general payments places this provider in the 95th percentile of 257 infectious disease providers in Michigan.

See all infectious disease providers in Michigan

Medicare billing

Part B allowed, 2024
$7,890
Medicare patients
24
Services billed
64

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other infectious disease in Detroit

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →